AppBrain
AppBrain
  • Apps
  • Apps being viewed right now Trending apps today Most popular apps All-time most installed apps Top rated apps iPhone and iPad apps
  • Intelligence ▾
    Intelligence overview → Track any Android app or your whole market
    Track & analyze
    Keyword Tracker & OptimizerTrack & improve Play rankings App Performance ReportOne-off PDF for any app StatisticsFree Android & Play market stats
    Promote your app
    Featured Apps App Links
  • Intelligence
  • Pricing
  • Dashboard
  • Sign up
  • Log in
Android Apps > Medical > Medicago 021 Subject App
App profile & analytics · Medical
Medicago 021 Subject App icon

Medicago 021 Subject App

by snapIoT Inc · Free · Version 1.1.7

“Medicago021 Phase II eDiary daily symptom trackerType a message” the developer's tagline

Availability No longer on Google Play
Rating on Google Play
2.40/5
7 ratings
Rating
2.40
7 reviews
Total installs
580
Best rank
–
not in the top lists
Last updated
December 14, 2020
1.1.7
AppBrain's verdict Removed

Medicago 021 Subject App is no longer on Google Play. It was there for 2 years, until October 2023. It was a niche app, with 580 installs. It had too few ratings to say what users thought.

Medicago 021 Subject App is made and published by snapIoT Inc. AppBrain is an independent app data site and isn't affiliated with snapIoT Inc. The app name, icon, screenshots and description belong to snapIoT Inc and are shown as published on Google Play.

About Medicago 021 Subject App

Medicago 021 Subject App was a medical app developed by snapIoT Inc. It was removed from Google Play Oct 2, 2023.

Install Statistics

Medicago 021 Subject App had been installed 580 times before it became unavailable.

User Ratings

Medicago 021 Subject App was rated 2.40 out of 5 stars, based on 7 ratings.

App Information

Medicago 021 Subject App was free. The app size was 31.26 MB. The last available version was 1.1.7. The last update was on December 14, 2020.

Technical Requirements

The app had a content rating of Everyone. The app had been available on Google Play since November 2020.

Description by snapIoT Inc (from Google Play)
Application in support of vaccine in clinical trials to determine safety for use in humans. eDiary collects signs and symptoms of reactions for seven days after the injection and reports data to study investigators. Study participants will receive notification reminders to complete their daily eDiary. Access to participate in this study requires informed consent by medical personnel. Only after consenting will participants receive an invitation to complete eDiaries. snapIoT and its platforms are HIPAA, California Privacy Rights Act, and GDPR compliant

Recent changes:
- Bug fixes
Show more Show less

More data about Medicago 021 Subject App

Price Free
Total installs 580
Rating 2.40 based on 7 ratings
Version 1.1.7
App size 31.3 MB
Number of libraries ?
Suitable for Everyone
Ads No ads

App Performance Report

Get a detailed PDF report for Medicago 021 Subject App with download trends, rating history, and key performance statistics — useful for competitive research or tracking your own app. Learn more

Get PDF Report — $29
This app is currently not available on Google Play.

Similar apps

Valneva icon Valneva
Parallel 6, Inc.
3.9
Free
1,000+
TrialMax App icon TrialMax App
Signant Health
4.3
Free
100,000+
Curebase icon Curebase
Curebase
4.7
Free
1,000+
CheckCOVID icon CheckCOVID
University of Nebraska Medical Center
3.3
Free
5,000+
Patient Cloud icon Patient Cloud
Medidata Solutions
4.4
Free
100,000+
Andaman7 My Health Records icon Andaman7 My Health Records
Andaman7
3.4
Free
10,000+
myStudyPartner+ icon myStudyPartner+
Boston Scientific, Inc.
4.3
Free
500+
Patient Cloud ePRO icon Patient Cloud ePRO
Medidata Solutions
4.3
Free
5,000+

Screenshots

Screenshots of this removed app
We kept the screenshots from before it was removed. Subscribe to see them.

Also available on the App Store

Medicago 021 Subject App icon Medicago 021 Subject App
Snapiot Inc
1.0
Free
1 ratings

More from snapIoT Inc

Konfident302 icon Konfident302
snapIoT Inc
0.0
Free
100+
ACHIEVE Site App icon ACHIEVE Site App
snapIoT Inc
0.0
Free
10+
ACHIEVE Patient App icon ACHIEVE Patient App
snapIoT Inc
0.0
Free
10+

Google Play Rating history and histogram

The year before it was removed from Google Play, up to October 2023

1
1
0
0
4

Changelog of Medicago 021 Subject App

Show changelog

Developer information for snapIoT Inc

snapIoT Inc

Sign in to see the developer's website

Address:

Share Medicago 021 Subject App

Comments on Medicago 021 Subject App for Android

We don't have enough comments to show example comments. Please check back later.

Technologies used by Medicago 021 Subject App

14 permissions
Subscribe to see full permission and library details

Frequently asked questions about Medicago 021 Subject App

Is Medicago 021 Subject App free?

Yes. Medicago 021 Subject App was free on Google Play.

Is Medicago 021 Subject App still available?

No. Medicago 021 Subject App was removed from Google Play. We last saw it there Oct 2, 2023.

Does Medicago 021 Subject App contain ads?

No. Google Play did not list Medicago 021 Subject App as containing ads.

How large is Medicago 021 Subject App?

Medicago 021 Subject App is 31.26 MB.

Is Medicago 021 Subject App suitable for children?

Google Play rates the content of Medicago 021 Subject App as suitable for everyone.

How many times has Medicago 021 Subject App been installed?

Google Play listed 500+ installs for Medicago 021 Subject App.

How do people rate Medicago 021 Subject App?

Medicago 021 Subject App scored 2.40 out of 5 stars, from 7 ratings on Google Play.

Who made Medicago 021 Subject App?

Medicago 021 Subject App was developed by snapIoT Inc. It was listed in the medical category on Google Play.

What are the best alternatives to Medicago 021 Subject App?

People looking at Medicago 021 Subject App also look at these medical apps: Valneva, TrialMax App, Curebase, CheckCOVID, Patient Cloud.

Price drops on Google Play Popular Medical Apps Apps other people are watching Top new apps Today's trending apps
Valneva icon Valneva
TrialMax App icon TrialMax App
Curebase icon Curebase
CheckCOVID icon CheckCOVID
Patient Cloud icon Patient Cloud
Andaman7 My Health Records icon Andaman7 My Health Records
myStudyPartner+ icon myStudyPartner+
Patient Cloud ePRO icon Patient Cloud ePRO
Overview History Reviews Technology
AppBrain Intelligence premium content

Subscribe now to get full and unlimited access to AppBrain Intelligence. You'll have access to:

  • App Intelligence dashboard (performance timeline, competitor comparison, country rankings, insight cards)
  • Detailed ranking data per app
  • Full timeline per developer
  • Device market shares data per country
  • Unlimited keyword tracking
1 Month

$75/mo
(billed every month)

SAVE 0%
Subscribe
3 Months

$65/mo
($195 billed every 3 months)

SAVE 13%
Subscribe
1 Year

$57.50/mo
($690 billed every year)

SAVE 23%
Subscribe
Each subscription will automatically renew 3 days before the expiration date for the same time period. Subscriptions can be cancelled at any time before the renewal.

AppBrain is an app data site, we track rankings, ratings, installs for all apps and games on Google Play and the App Store. AppBrain doesn't host app files or APKs, all install links go directly to the official store. All trademarks are owned by their respective owners.

More apps

  • Top Android apps being viewed
  • Wysa: Mental Wellbeing AI for Android
  • Send files to TV
  • StardustTV - Movies & Dramas

App statistics

  • Android statistics
  • Google Play Developer stats
  • Trending Android Apps
  • Trending iOS apps
  • Top popular Apps
  • Buy the best Android phone
  • Buy & sell app businesses

About AppBrain

  • Contact
  • Privacy
  • Documentation
  • DMCA takedowns
  • Articles
  • Blog
  • Android Interstitial Ads: Best practices to optimize your app's earnings
© 2010-2026 - AppBrain